Federated Hermes’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-154,192
Closed -$4.4M 2132
2024
Q3
$4.4M Buy
+154,192
New +$4.4M 0.01% 748
2024
Q1
Sell
-2,979
Closed -$126K 2081
2023
Q4
$126K Sell
2,979
-356,609
-99% -$15M ﹤0.01% 1569
2023
Q3
$13.8M Buy
359,588
+310,163
+628% +$11.9M 0.04% 459
2023
Q2
$938K Sell
49,425
-3,067
-6% -$58.2K ﹤0.01% 1157
2023
Q1
$814K Buy
52,492
+9,924
+23% +$154K ﹤0.01% 1234
2022
Q4
$756K Buy
42,568
+32,708
+332% +$581K ﹤0.01% 1225
2022
Q3
$55K Sell
9,860
-1,872,491
-99% -$10.4M ﹤0.01% 1661
2022
Q2
$7.34M Sell
1,882,351
-21,543
-1% -$84K 0.02% 614
2022
Q1
$10.5M Buy
1,903,894
+1,404,404
+281% +$7.74M 0.02% 592
2021
Q4
$4.26M Buy
499,490
+486,456
+3,732% +$4.14M 0.01% 858
2021
Q3
$113K Buy
+13,034
New +$113K ﹤0.01% 1756
2021
Q1
Sell
-171,059
Closed -$7.9M 2282
2020
Q4
$7.9M Buy
171,059
+149,193
+682% +$6.89M 0.02% 698
2020
Q3
$769K Buy
+21,866
New +$769K ﹤0.01% 1349